journal article·2019-10-02Open access

Electrochemically Controlled Dissolution of Nanocarbon–Cellulose Acetate Phthalate Microneedle Arrays

Ashleigh Anderson, Catherine Hegarty, Charnete Casimero, James Davis

ACS Applied Materials & Interfaces· Volume 11· Issue 39

Abstract

Transdermal microneedles have captured the attention of researchers in relation to a variety of applications, and silicone-based molds required to produce these systems are now widely available and can be readily manufactured on the lab bench. The production of nanocomposite microneedle arrays through micromolding techniques is described. The formulation of nanoparticulate carbon along with pH sensitive cellulose acetate phthalate as a polymeric binder is shown to produce conductive microneedles whose swelling/dissolution properties can be controlled electrochemically. Through exploiting hydrogen evolution at the microneedle array, changes in local pH can induce swelling within the needle structure and could lay the foundations for a new approach to the smart device controlled delivery of therapeutic agents. The surface modification of the carbon needles with palladium and cysteine is critically assessed from sensing and drug delivery perspectives.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Advancements in Transdermal Drug Delivery · Neuroscience and Neural Engineering · Lipid Membrane Structure and Behavior

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

School of Engineering, Ulster University, Jordanstown, Northern Ireland BT37 0QB

Funding

Department for the Economy Northern Ireland · European Unions Interreg Programme

References (39)

Show source-provided references
1. 10.1016/j.addr.2003.10.02310.1016/j.addr.2003.10.023 ↗
2. 10.1016/j.mser.2016.03.00110.1016/j.mser.2016.03.001 ↗
3. 10.3109/10717544.2014.98630910.3109/10717544.2014.986309 ↗
4. 10.1007/s13346-017-0466-410.1007/s13346-017-0466-4 ↗
5. 10.3390/s1905102810.3390/s19051028 ↗
6. 10.1016/j.jddst.2019.01.00210.1016/j.jddst.2019.01.002 ↗
7. 10.1016/j.jddst.2018.03.02110.1016/j.jddst.2018.03.021 ↗
8. 10.1080/03639045.2018.153949710.1080/03639045.2018.1539497 ↗
9. 10.1016/j.ejpb.2019.01.00510.1016/j.ejpb.2019.01.005 ↗
10. 10.3390/medicines502005010.3390/medicines5020050 ↗
11. 10.1007/s11095-010-0101-210.1007/s11095-010-0101-2 ↗
12. 10.1016/j.matchemphys.2019.01.05210.1016/j.matchemphys.2019.01.052 ↗
13. 10.1016/j.elecom.2016.09.02410.1016/j.elecom.2016.09.024 ↗
14. 10.2174/15672011280352978310.2174/156720112803529783 ↗
15. 10.1016/j.jbiotec.2012.06.03610.1016/j.jbiotec.2012.06.036 ↗
16. 10.1111/jphp.1269410.1111/jphp.12694 ↗
17. 10.1002/jps.2338910.1002/jps.23389 ↗
18. 10.1289/ehp.110399810.1289/ehp.1103998 ↗
19. 10.1016/j.elecom.2015.08.00810.1016/j.elecom.2015.08.008 ↗
20. 10.1016/j.nanoen.2016.02.04410.1016/j.nanoen.2016.02.044 ↗
21. 10.1016/j.jelechem.2016.12.03710.1016/j.jelechem.2016.12.037 ↗
22. 10.1016/j.ijhydene.2018.01.03010.1016/j.ijhydene.2018.01.030 ↗
23. 10.1016/j.ijhydene.2019.01.29410.1016/j.ijhydene.2019.01.294 ↗
24. 10.1021/acscatal.5b0248510.1021/acscatal.5b02485 ↗
25. 10.1016/j.ijhydene.2016.08.19510.1016/j.ijhydene.2016.08.195 ↗
26. 10.1016/j.ijhydene.2016.11.10010.1016/j.ijhydene.2016.11.100 ↗
27. 10.1016/j.ijhydene.2015.09.11410.1016/j.ijhydene.2015.09.114 ↗
28. 10.1016/j.jcis.2018.09.01810.1016/j.jcis.2018.09.018 ↗
29. 10.1016/j.apmt.2018.09.00110.1016/j.apmt.2018.09.001 ↗
30. 10.1016/j.electacta.2016.12.01510.1016/j.electacta.2016.12.015 ↗
31. 10.1016/j.jpowsour.2015.05.02310.1016/j.jpowsour.2015.05.023 ↗
32. 10.1021/acsami.8b1977010.1021/acsami.8b19770 ↗
33. 10.1023/B:STUC.0000037902.93420.2810.1023/B:STUC.0000037902.93420.28 ↗
34. 10.1021/ja00312a07810.1021/ja00312a078 ↗
35. 10.1021/jp210571510.1021/jp2105715 ↗
36. 10.1016/j.jelechem.2010.09.00110.1016/j.jelechem.2010.09.001 ↗
37. 10.1021/la034245b10.1021/la034245b ↗
38. 10.1021/acsomega.7b0199110.1021/acsomega.7b01991 ↗
39. Baran R. · 201010.3109/9781841847641 ↗